Establishment Labs Holdings (ESTA) Short-Term Debt issuances (2025)
Establishment Labs Holdings' quarterly Short-Term Debt issuances came in at $5.0 million in Q3 2025.
Establishment Labs Holdings has reported Short-Term Debt issuances for 1 years, with the latest figure at $5.0 million in Q3 2025.
- For the quarter ending Q3 2025, Short-Term Debt issuances changed N/A year-over-year to $5.0 million; the trailing twelve-month figure through Dec 2025 stood at $5.0 million (changed N/A YoY), and the FY2025 full-year result was $10.0 million, changed N/A from the prior year.
- Short-Term Debt issuances for Q3 2025 stood at $5.0 million.
- The five-year high for Short-Term Debt issuances was $5.0 million in Q3 2025, with the low at $5.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 31.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -1.23 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -1.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 37.80 Mn |
| 10 | Establishment Labs Holdings | 2.04 Bn | 1.97 Bn | 42.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 5.00 Mn |
| Sep 30, 2025 | 5.00 Mn |